CAS 38964-33-9: N-Formylloline
Formula:C9H14N2O2
InChI:InChI=1S/C9H14N2O2/c1-10(5-12)8-7-4-11-3-2-6(13-7)9(8)11/h5-9H,2-4H2,1H3
InChI key:InChIKey=YHLKXYXFUCTURZ-UHFFFAOYSA-N
SMILES:O=CN(C)C1C2OC3CCN(C2)C31
- Synonyms:
- N-Formylloline
- N-[(2R,3R,3aS,4S,6aS)-Hexahydro-2,4-methano-4H-furo[3,2-b]pyrrol-3-yl]-N-methylformamide
- 2,4-Methano-4H-furo[3,2-b]pyrrole, formamide deriv.
- Formamide, N-(hexahydro-2,4-methano-4H-furo[3,2-b]pyrrol-3-yl)-N-methyl-, [2R-(2α,3α,3aβ,4α,6aβ)]-
- Formamide, N-[(2R,3R,3aS,4S,6aS)-hexahydro-2,4-methano-4H-furo[3,2-b]pyrrol-3-yl]-N-methyl-
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N-Formylloline REF: 4Z-L-155006CAS: 38964-33-9 | - - - | To inquire | Mon 10 Mar 25 |
| N-Formylloline-d3 REF: 4Z-L-155007CAS: 38964-33-9 | - - - | To inquire | Mon 10 Mar 25 |
 | N-Formylloline-d3 REF: TR-F700582CAS: 38964-33-9 | - - - | 2,844.00 € | Fri 11 Apr 25 |
 | N-Formylloline REF: 3D-NBA96433CAS: 38964-33-9 | Min. 95% | 2,316.00 € | Mon 14 Apr 25 |
Ref: 4Z-L-155006
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 10 Mar 2025
Ref: 4Z-L-155007
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 10 Mar 2025
N-Formylloline-d3
Controlled ProductCAS:38964-33-9
Stability Hygroscopic Applications N-Formylloline-d3 is the labelled analog of N-Formyllonline, a pyrrolizidine alkaloid found in …
Formula:
C9H11D3N2O2
Color and Shape:
Neat
Molecular weight:
185.24
Ref: TR-F700582
| 1mg | 2,844.00 € |
Estimated delivery in United States, on Friday 11 Apr 2025
N-Formylloline
CAS:38964-33-9
N-Formylloline is a kinase inhibitor analog that has been developed for medicinal use as an …
Formula:
C9H14N2O2
Purity:
Min. 95%
Molecular weight:
182.22 g/mol
Ref: 3D-NBA96433
| 1mg | 2,316.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025
